# US 2015/0104793 A1 · Non-invasive fetal genetic screening by digtal analysis

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0104793 A1
- Document ID: US20150104793A1
- Status: Published application
- Kind: A1
- Application number: 14/581,225
- Filed: 2014-12-23
- Published: 2015-04-16
- Earliest claimed: 2006-02-02
- Assignees: The Board of Trustees of the Leland Stanford Junior University
- Applicants: The Board of Trustees of the Leland Stanford Junior University
- Inventors: STEPHEN QUAKE; HEI-MUN CHRISTINA FAN
- Web page: https://patentgrep.com/patent/US20150104793A1

## CPC

- C12Q 1/6883: for diseases caused by alterations of genetic material
- C12Q 1/6809: Methods for determination or identification of nucleic acids involving differential detection
- C12Q 1/6851: Quantitative amplification
- C12Q 1/6858: Allele-specific amplification
- C12Q 1/6881: for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
- C12Q 2600/156: Polymorphic or mutational markers
- C12Q 2600/158: Expression markers
- Y10T 436/143333: Saccharide [e.g., DNA, etc.]
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- Y10T: TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION

## Abstract

The present methods are exemplified by a process in which maternal blood containing fetal DNA is diluted to a nominal value of approximately 0.5 genome equivalent of DNA per reaction sample. Digital analysis is then be used to detect aneuploidy, such as the trisomy that causes Down Syndrome. Since aneuploidies do not present a mutational change in sequence, and are merely a change in the number of chromosomes, it has not been possible to detect them in a fetus without resorting to invasive techniques such as amniocentesis or chorionic villi sampling. Digital amplification allows the detection of aneuploidy using massively parallel amplification and detection methods, examining, e.g., 10,000 genome equivalents.

## Claims

### Claim 1

A method for identifying a risk for an aneuploidy on a first chromosome of a fetus carried by mother, the method comprising:
a) providing a sample of nucleic acids derived from a cell-free portion of a maternal blood sample, wherein said sample contains a mixture of maternal and fetal DNA;
b) selectively detecting preselected sequences on at least the first chromosome and preselected sequences on a second chromosome in the sample;
c) determining a first value for an amount of a first preselected sequence representing a first location on the first chromosome, wherein the first value:
i) includes a contribution from detection of the maternal DNA and the fetal DNA, and
ii) is not based on separately determining contributions to the amount at the first location from the maternal DNA and the fetal DNA;
d) determining a second value for an amount of a second preselected sequence representing a second location on the second chromosome, wherein the second value:
i) includes a contribution from detection of the maternal DNA and the fetal DNA; and
ii) is not based on separately determining contributions to the amount at the second location from the maternal DNA and the fetal DNA; and
e) conducting a statistical analysis to analyze for aneuploidy of the first chromosome in the fetus using the first value, the second value, and one or more additional values for additional samples of nucleic acids derived from cell-free portions of additional maternal blood samples that contain mixtures of maternal and fetal DNA.

### Claim 2 (depends on 1)

The method of claim 1, further comprising:
a) determining a third value for an amount of a third preselected sequence at a third location on a third chromosome, wherein the third value:
i) includes a contribution from detection of the maternal DNA and the fetal DNA; and
ii) is not based on separately determining contributions to the amount at the second location from the maternal DNA and the fetal DNA; and
b) conducting the statistical analysis to analyze for aneuploidy of the first chromosome in the fetus using the first value, the second value, and the third value.

### Claim 3 (depends on 1)

The method of claim 1, further comprising:
a) determining multiple values for multiple preselected sequences at multiple different locations on the first chromosome; and
b) determining multiple values for multiple preselected sequences at multiple different locations on the second chromosome,
wherein conducting the statistical analysis comprises analyzing for aneuploidy of the first chromosome in the fetus using the multiple values for the multiple preselected sequences at the multiple different locations on the first chromosome and the multiple values for the multiple preselected sequences at the multiple different locations on the second chromosome.

### Claim 4 (depends on 3)

The method of claim 3, wherein the multiple preselected sequences at multiple different locations on the first chromosome and the multiple preselected sequences at multiple different locations on the second chromosome are detected using probes directed to the locations on the first and second chromosomes.

### Claim 5 (depends on 3)

The method of claim 3, further comprising summing the values for the multiple preselected sequences at multiple different locations on the first chromosome to provide a value for the first chromosome, wherein conducting the statistical analysis comprises analyzing for aneuploidy of the first chromosome in the fetus using the value for the first chromosome.

### Claim 6 (depends on 1)

The method of claim 1, wherein the statistical analysis comprises a t test.

### Claim 7 (depends on 1)

The method of claim 1, wherein the detection method comprises digital PCR.

### Claim 8 (depends on 1)

The method of claim 1, wherein conducting the statistical analysis comprises comparing:
a) a ratio of a value for the first chromosome to a value for one or more chromosomes including the second chromosome, wherein said values are derived from detection reactions on the maternal blood sample being tested; and
b) a value based on multiple ratios of a value for the first chromosome to a value for one or more chromosomes including the second chromosome, wherein said values are derived from analysis of multiple other maternal samples.

### Claim 9 (depends on 1)

The method of claim 1, wherein conducting the statistical analysis further comprises taking into account the fraction level of fetal DNA in the sample of nucleic acids.

### Claim 10

A method for identifying a risk for an aneuploidy on a first chromosome of a fetus carried by a mother, the method comprising:
a) providing a sample of nucleic acids derived from a cell-free portion of a maternal blood sample, wherein said sample contains a mixture of maternal and fetal DNA;
b) selectively detecting preselected sequences on at least the first chromosome and a second chromosome in the sample using probes to preselected locations on the first chromosome and the second chromosome;
c) determining first multiple values for amounts of multiple preselected sequences at multiple different locations on the first chromosome, wherein the first multiple values:
i) include a contribution from detection of the maternal DNA and the fetal DNA; and
ii) are not based on separately determining contributions to the amounts at the multiple different locations on the first chromosome from the maternal DNA and the fetal DNA; and
d) determining second multiple values for amounts of multiple preselected sequences at multiple different locations on the second chromosome, wherein the second multiple values:
i) include a contribution from detection of the maternal DNA and the fetal DNA; and
ii) are not based on separately determining contributions to the amounts at the multiple different locations on the second chromosome from the maternal DNA and the fetal DNA; and
e) conducting a statistical analysis to analyze for aneuploidy of the first chromosome in the fetus using the first multiple values, the second multiple values, and one or more additional values for additional samples of nucleic acids derived from cell-free portions of additional maternal blood samples that contain mixtures of maternal and fetal DNA.

### Claim 11 (depends on 10)

The method of claim 10, further comprising:
a) determining a third value for an amount of a third preselected sequence at a location on a third chromosome, wherein the third value:
i) includes a contribution from detection of the maternal DNA and the fetal DNA;
ii) is not based on separately determining contributions to the amount at the location on the third chromosome from the maternal DNA and the fetal DNA; and
b) conducting the statistical analysis further comprises conducting the statistical analysis to analyze for aneuploidy of the first chromosome in the fetus using the third value.

### Claim 12 (depends on 10)

The method of claim 10, wherein conducting the statistical analysis comprises comparing:
a) a ratio of a value for the first chromosome to a value for one or more chromosomes, wherein said value includes the second chromosome derived from detection reactions on the sample of nucleic acids; and
b) a value based on multiple ratios of a value for the first chromosome to a value for one or more chromosomes including the second chromosome, wherein said values are derived from analysis of multiple other maternal samples.

### Claim 13 (depends on 1)

The method of claim 1, wherein conducting the statistical analysis further comprises taking into account the fraction level of fetal DNA in the sample of nucleic acids.

### Claim 14 (depends on 10)

The method of claim 10, further comprising summing the first multiple values to provide a value for the first chromosome, wherein conducting the statistical analysis comprises analyzing for aneuploidy of the first chromosome in the fetus using the value for the first chromosome.

### Claim 15

A method for identifying a risk for an aneuploidy on a first chromosome of a fetus carried by mother, the method comprising:
a) providing a sample of nucleic acids derived from a cell-free portion of a maternal blood sample that contains a mixture of maternal and fetal DNA;
b) selectively detecting preselected sequences on at least the first chromosome and a second chromosome in the sample using probes to preselected locations on the first chromosome and the second chromosome;
c) determining a first value for an amount of a first preselected sequence representing a first location on the first chromosome, wherein the first value:
i) includes a contribution from detection of the maternal DNA and the fetal DNA; and
ii) is not based on separately determining contributions to the amount at the first location from the maternal DNA and the fetal DNA;
d) determining a second value for an amount of a second preselected sequence representing a second location on the second chromosome, wherein the second value:
i) includes a contribution from detection of the maternal DNA and the fetal DNA; and
ii) is not based on separately determining contributions to the amount at the second location from the maternal DNA and the fetal DNA; and
e) conducting a statistical analysis to analyze for aneuploidy of the first chromosome in the fetus using the first value, the second value, and one or more additional values for additional samples of nucleic acids derived from cell-free portions of additional maternal blood samples that contain mixtures of maternal and fetal DNA.

### Claim 16 (depends on 15)

The method of claim 15, further comprising:
a) determining a third value for an amount of a third preselected sequence at a third location on a third chromosome, wherein the third value:
i) includes a contribution from detection of the maternal DNA and the fetal DNA; and
ii) is not based on separately determining contributions to the amount at the second location from the maternal DNA and the fetal DNA; and
b) conducting the statistical analysis comprises conducting the statistical analysis to analyze for aneuploidy of the first chromosome in the fetus using the first value, the second value, and the third value.

### Claim 17 (depends on 16)

The method of claim 16, wherein the statistical analysis comprises a t test.

### Claim 18 (depends on 16)

The method of claim 16, wherein conducting the statistical analysis comprises comparing:
a) a ratio of a value for the first chromosome to a value for one or more chromosomes including the second chromosome, wherein said values are derived from detection reactions on the maternal blood sample being tested; and
b) a value based on multiple ratios of a value for the first chromosome to a value for one or more chromosomes including the second chromosome, wherein said values are derived from analysis of multiple other maternal samples.

### Claim 19 (depends on 18)

The method of claim 18, wherein the value for the first chromosome is determined by summing the first value and a one or more values for an amount of a additional preselected sequences representing additional locations on the first chromosome.

### Claim 20 (depends on 16)

The method of claim 16, wherein conducting the statistical analysis further comprises taking into account the fraction level of fetal DNA in the sample of nucleic acids.

### Claim 21

A method for identifying a risk for an aneuploidy on a first chromosome of a fetus carried by a mother, the method comprising:
a) providing a sample of nucleic acids derived from a cell-free portion of a maternal blood sample, wherein said sample contains a mixture of maternal and fetal DNA;
b) selectively detecting a first preselected sequence of a first location on the first chromosome, wherein the first preselected sequence is common to all copies of the first chromosome in the sample of nucleic acids;
c) selectively detecting a second preselected sequence of a second location on a second chromosome, wherein the second preselected sequence is common to all copies of the second chromosome in the sample of nucleic acids;
d) determining a first value using an amount of the first preselected sequence;
e) determining a second value using an amount of the second preselected sequence, and
f) conducting a statistical analysis to analyze for aneuploidy of the first chromosome in the fetus using the first value, the second value, and one or more additional values for additional samples of nucleic acids derived from cell-free portions of additional maternal blood samples that contain mixtures of maternal and fetal DNA.

### Claim 22 (depends on 21)

The method of claim 21, further comprising:
a) determining multiple values for multiple preselected sequences at multiple different locations on the first chromosome; and
b) determining multiple values for multiple preselected sequences at multiple different locations on the second chromosome,
wherein conducting the statistical analysis comprises analyzing for aneuploidy of the first chromosome in the fetus using the multiple values for the multiple preselected sequences at the multiple different locations on the first chromosome and the multiple values for the multiple preselected sequences at the multiple different locations on the second chromosome.

### Claim 23 (depends on 22)

The method of claim 22, wherein the multiple preselected sequences at multiple different locations on the first chromosome and the multiple preselected sequences at multiple different locations on the second chromosome are detected using probes directed to the locations on the first and second chromosomes.

### Claim 24 (depends on 22)

The method of claim 22, further comprising summing the values for the multiple preselected sequences at multiple different locations on the first chromosome to provide a value for the first chromosome, wherein conducting the statistical analysis comprises analyzing for aneuploidy of the first chromosome in the fetus using the value for the first chromosome.

### Claim 25 (depends on 1)

The method of claim 1, wherein conducting the statistical analysis further comprises taking into account the fraction level of fetal DNA in the sample of nucleic acids.
